Did generic drug makers act as a 'private sector cartel?'
Clip: 05/15/2019 | 5m 44s | Video has closed captioning.
Affordable health care is a persistent concern for Americans and a topic of great political debate. Typically, generic prescription drugs offer a cheaper alternative to name brands, but a new multi-state lawsuit alleges that their manufacturers have been artificially raising prices. John Yang talks to William Tong, attorney general of Connecticut, whose office has been leading the investigation.
Problems Playing Video? | Closed Captioning